Drugs - Real World Outcomes

397 papers and 2.7k indexed citations i.

About

The 397 papers published in Drugs - Real World Outcomes in the last decades have received a total of 2.7k indexed citations. Papers published in Drugs - Real World Outcomes usually cover Geriatrics and Gerontology (84 papers), Cardiology and Cardiovascular Medicine (72 papers) and Economics and Econometrics (52 papers) specifically the topics of Pharmaceutical Practices and Patient Outcomes (82 papers), Health Systems, Economic Evaluations, Quality of Life (38 papers) and Pharmacovigilance and Adverse Drug Reactions (37 papers). The most active scholars publishing in Drugs - Real World Outcomes are Maria Gustafsson, Takahiro Hirano, Elizabeth E. Roughead, Marie‐Hélène Lafeuille and Thomas Laurent.

In The Last Decade

Fields of papers published in Drugs - Real World Outcomes

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Drugs - Real World Outcomes. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Drugs - Real World Outcomes

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Drugs - Real World Outcomes. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Drugs - Real World Outcomes with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025